Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoplasm, Residual × Hematologic Tests × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 11 Breast Neoplasms 8 Prostatic Neoplasms 4 Colorectal Neoplasms 4 Polycystic Ovary Syndrome 3 Neoplasm Metastasis 3 Carcinoma, Non-Small-Cell Lung 3 Pancreatic cancer, adult 2 Ovarian Neoplasms 2 Lymphoma 2 Lung Neoplasms 2 Carcinoma, Hepatocellular 2 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Testicular Germ Cell Tumor 1 Stroke 1 Skin Neoplasms 1 Sezary Syndrome 1 Retroviridae Infections 1 Renal Insufficiency 1 Prostate Cancer Metastatic 1 Pancreatic carcinoma, familial 1 Pancreatic Neoplasms 1 Ovarian Germ Cell Cancer 1 Oligomenorrhea 1 Obesity 1 Non-alcoholic Fatty Liver Disease 1 Neoplastic Cells, Circulating 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasm, Residual 1

Interventions

Blood Specimen Collection 6 Liquid Biopsy 3 Chemotherapy, Adjuvant 2 trastuzumab deruxtecan 1 pegaspargase 1 Vincristine 1 Trastuzumab 1 Transplantation, Autologous 1 Prednisone 1 Methotrexate 1 Mercaptopurine 1 Hematologic Tests 1 Drug Therapy 1 Doxorubicin 1 Daunorubicin 1 Cytarabine 1 Cyclophosphamide 1 Clonal Evolution 1 Anti-Inflammatory Agents, Non-Steroidal 1 Aminolevulinic Acid 1 Ado-Trastuzumab Emtansine 1 Adjuvants, Pharmaceutic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07514715 2026-04-13

RT4

The Lymphoma Academic Research Organisation

Not yet recruiting

Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡